Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bad medicine: gabapentin and pregabalin.

× No keyword cloud information.

13 in total

Review 1. Abuse and Misuse of Pregabalin and Gabapentin.

Authors: Kirk E Evoy; Megan D Morrison; Stephen R Saklad
Journal: Drugs Date: 2017-03 Impact factor: 9.546

Review 2. Misuse and abuse of pregabalin and gabapentin: cause for concern?

Authors: Fabrizio Schifano
Journal: CNS Drugs Date: 2014-06 Impact factor: 5.749

3. Bad Medicine: Red drugs.

Authors: Des Spence
Journal: Br J Gen Pract Date: 2017-02 Impact factor: 5.386

4. Bad medicine: the menopause.

Authors: Des Spence
Journal: Br J Gen Pract Date: 2016-06 Impact factor: 5.386

5. A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.

Authors: Stefania Chiappini; Fabrizio Schifano
Journal: CNS Drugs Date: 2016-07 Impact factor: 5.749

6. Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.

Authors: Valentina Peta; Chantal Tse; Hugo Perazzo; Mona Munteanu; Yen Ngo; An Ngo; Nittia Ramanujam; Lea Verglas; Maxime Mallet; Vlad Ratziu; Dominique Thabut; Marika Rudler; Vincent Thibault; Ina Schuppe-Koistinen; Dominique Bonnefont-Rousselot; Bernard Hainque; Françoise Imbert-Bismut; Michael Merz; Gerd Kullak-Ublick; Raul Andrade; Florian van Boemmel; Eckart Schott; Thierry Poynard
Journal: PLoS One Date: 2017-12-29 Impact factor: 3.240

Review 7. Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials.

Authors: Harsha Shanthanna; Ian Gilron; Manikandan Rajarathinam; Rizq AlAmri; Sriganesh Kamath; Lehana Thabane; Philip J Devereaux; Mohit Bhandari
Journal: PLoS Med Date: 2017-08-15 Impact factor: 11.069

Review 8. Review about gabapentin misuse, interactions, contraindications and side effects.

Authors: Gabriel C Quintero
Journal: J Exp Pharmacol Date: 2017-02-09

9. Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study.

Authors: Luk Van Baelen; Karin De Ridder; Jérôme Antoine; Lies Gremeaux
Journal: Arch Public Health Date: 2018-03-19

Review 10. Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials.

Authors: Igho J Onakpoya; Elizabeth T Thomas; Joseph J Lee; Ben Goldacre; Carl J Heneghan
Journal: BMJ Open Date: 2019-01-21 Impact factor: 2.692